Clinical Trials Browser

Phase 1/2 × INDUSTRY × ProMune × Clear all

NCT00031278 2011-05-30

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Phase 1/2 Completed

Carcinoma, Neoplasm Metastasis, Neoplasms

NCT00043407 2009-02-12

CPG 7909 in Patients Wih Stage IV Renal Cell Cancer

Phase 1/2 Completed

Carcinoma, Renal Cell

NCT00043420 2009-02-12

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Phase 1/2 Completed

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous